TG Therapeutics, Inc. (TGTX)

55.98 -0.72 (-1.28%) USD  |  NASDAQ  |  Sep 04, 16:00
56.00 +0.02 (+0.03%) After-Hours: 20:00
More

TG Therapeutics SG&A Expense (TTM) : 296.46M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for TGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 296.46M
March 31, 2026 269.92M
December 31, 2025 232.03M
September 30, 2025 208.25M
June 30, 2025 186.84M
March 31, 2025 170.05M
December 31, 2024 154.30M
September 30, 2024 146.49M
June 30, 2024 137.29M
March 31, 2024 129.22M
December 31, 2023 122.70M
September 30, 2023 114.06M
June 30, 2023 95.54M
March 31, 2023 77.46M
December 31, 2022 70.00M
September 30, 2022 79.91M
June 30, 2022 100.56M
March 31, 2022 121.94M
December 31, 2021 128.09M
September 30, 2021 139.54M
June 30, 2021 139.93M
March 31, 2021 120.35M
December 31, 2020 107.85M
September 30, 2020 71.05M
June 30, 2020 38.66M
Date Value
March 31, 2020 26.95M
December 31, 2019 15.03M
September 30, 2019 9.884M
June 30, 2019 7.938M
March 31, 2019 10.90M
December 31, 2018 15.16M
September 30, 2018 18.32M
June 30, 2018 21.83M
March 31, 2018 17.90M
December 31, 2017 16.33M
September 30, 2017 13.04M
June 30, 2017 11.73M
March 31, 2017 12.50M
December 31, 2016 9.889M
September 30, 2016 10.53M
June 30, 2016 9.654M
March 31, 2016 13.01M
December 31, 2015 15.63M
September 30, 2015 16.82M
June 30, 2015 18.32M
March 31, 2015 17.58M
December 31, 2014 15.79M
September 30, 2014 13.63M
June 30, 2014 11.22M
March 31, 2014 7.709M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Krystal Biotech, Inc. 159.89M
Alnylam Pharmaceuticals, Inc. 1.318B
BioMarin Pharmaceutical, Inc. 1.368B
Cytokinetics, Inc. 370.47M
Exelixis, Inc. 533.92M